LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes

Acta Diabetologica

Volumn 39, Issue 4, 2002, Pages 215-220

  Wagner A M ^a   Jorba, O ^a   Rigla, M ^a   Alonso, E ^a   Ordonez Llanos J ^a   Perez A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

LDL phenotype B; LDL size; LDL cholesterol apolipoprotein B ratio; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SEX RATIO; STATISTICAL ANALYSIS; AGED; BLOOD; CHEMISTRY; FORECASTING; GENETICS; MIDDLE AGED;

AGED; APOLIPOPROTEINS B; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARTICLE SIZE; PHENOTYPE; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 0036902239     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920200037     Document Type: Article

References (29)

1. Pyörälä K, Pedersen TR, Kjekshus, Faergeman O, Olsson AG, Thorgeirsson G and The Scandinavian Simvastatin Survival Study Group (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20:614-620
2. Caixàs A, Ordóñez-Llanos J, de Leiva A, Payés A, Homs R, Pérez A (1997) Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 46:1207-1213
3. Wägner AM, Pérez A, Calvo F, Bonet R, Castellví A, Ordóñez J (1999) Apolipoprotein B identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care 22:812-817
4. Austin MA, Breslow JL, Hennekens CH, Buring JL, Willett WC, Krauss R (1988) Low density lipoprotein subclass pattern and risk of myocardial infarction. JAMA 260:1917-1921
5. Campos H, Blijlevens E, McNamara J, Ordovás JM, Posner BM, Wilson PWF, Castelli WP, Schaefer EJ (1992) LDL particle size distribution. Results form the Framingham Offspring Study. Arterioscler Thromb 12:1410-1419
6. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després J-P (1996) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Québec Cardiovascular Study. Circulation 95:69-75
7. Mykkänen L, Kuusisto J, Haffner SM, Laakso M, Austin MA (1999) LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol 19:2742-2748
8. Abate N, Vega GL, Garg A, Grundy SM (1995) Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis 118:111-122
9. Hokanson JE, Austin MA, Brunzell JD (1997) Measurement and clinical significance of low-density lipoprotein subclasses. In: Rifai N, Warnick GR, Dominiczak MH (eds) Handbook of Lipoprotein Testing. AACC Press, Washington, pp 177-198
10. Expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (1993) Summary of the Second Report or the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 269:3015-3023
11. Friedewald WT, Levy RJ, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502
12. Planella T, Cortés M, Martínez-Brú C, González-Sastre F, Ordóñez-Llanos J (1997) Calculation of LDL cholesterol using apolipoprotein B for the phenotypical classification of non-chylomicronemic dyslipemia. Clin Chem 43:808-815
13. Wägner AM, Sänchez-Quesada JL, Pérez A, Rigla M, Blanco-Vaca F, Ordóñez-Llanos J (2000) Inaccuracy of calculated LDL cholesterol in type 2 diabetes: Consequences for patient risk classification and therapeutic decision. Clin Chem 46:1830-1832
14. Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturating polyacrylamide gradient gel electrophoresis. In: Segrest JP, Albers LL (eds) Methods in Enzymology: Plasma Lipoproteins. Academy Press, New York, pp 417-431
15. Altman DG (1991) Some common problems in medical research. In: Altman DG (ed) Practical Statistics for Medical Research. Chapman and Hall, New York, pp 396-437
16. European Diabetes Policy Group (1999) A desktop guide to type 2 diabetes mellitus. Diabetic Med 16:716-730
17. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ (1987) Effect of gender, age and lipids status on low density lipoprotein subfraction distribution: Results from the Framingham Offspring Study. Arteriosclerosis 7:483-490
18. Tchernof A, Lamarche B, Prud'home D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Després JP (1996) The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity and hyperinsulinemia in men. Diabetes Care 19:629-637
19. Singh ATK, Rainwater DL, Haffner SM, VandeBerg JL, Shelledy WR, Moore PH, Dyer TD (1995) Effect of diabetes on lipopoprotein size. Arterioscler Thromb Vasc Biol 15:1805-1811
20. Lahdenperä S, Sane T, Vuorinen-Markkola H, Knudsen P, Taskinen MR (1995) LDL particle size in mildly hypertriglyceridemic subjects: No relation to insulin resistance or diabetes. Atherosclerosis 113:227-236
21. Hirano T, Oi K, Sakai S, Kashiwazaki K, Adachi M, Yoshino G (1998) High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: A possible role of postprandial lipemia. Atheroclerosis 141:777-785
22. Rainwater DL (2000). Lipoprotein correlates of LDL particle size. Atherosclerosis 148:151-158
23. American Diabetes Association (2000) Management of dyslipidaemia in adults with diabetes. Diabetes Care 23[Suppl 1]:S57-S60
24. Superko HR, Krauss RM (1992) Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis 95:69-76
25. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253
26. Syvänne M, Ahola M, Lahdenperä S, Kahri J, Kuusi T, Virtanan KS, Taskinen M-R (1996) Regulation of low-density lipoprotein particles in NIDDM and coronary artery disease: Importance of serum triglycerides. Diabetologia 39:453-461
27. Ortolá J, Castineiras MJ, Fuentes-Arderiu X (1992) Biological variation data applied to the selection of serum lipid ratios used as risk markers of coronary heart disease. Clin Chem 38:56-59
28. Furuya D, Yagihashi A, Nasu S, Wndoh T, Nakamura T, Kaneko R, Kamagata C, Kobayashi D, Watanabe N (2000) LDL particle size by gradient-gel electrophoresis cannot be estimated by LDL-cholesterol/apolipoprotein B ratios. Clin Chem 46:1202-1203
29. Griffin BA, Minihane AM, Furlonger N, Chapman C, Murphy M, Williams D, Wright JJ, Williams CM (1999) Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin Sci 97:269-276